Search Results 281-290 of 17384 for Proto-oncogene
The primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC.
Latest stories ; Mayo Clinic Cancer Center researchers identify promising drug to treat gastrointestinal cancers featured image. Cancer. Mayo Clinic Cancer ...
Learn about these malignant brain tumors that happen most often in babies and young children. Treatments include surgery, radiation therapy and ...
Learn about these tumors that form from reproductive cells. Explore treatment options, including surgery, chemotherapy and radiation therapy.
The purpose of this study is to assess the side effects and best dose of ATR kinase inhibitor VX-970 when given together with whole brain radiation therapy for ...
Mayo Clinic Researchers Find Two Oncogenes Join to Drive Lung Squamous Cell Carcinoma. Kevin Punsky. February 10, 2014. Infectious Diseases. When Cats Bite: 1 ...
Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying cellular responses to DNA damage induced by topoisomerase poisons.
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment ...
PI3K-delta inhibitor TGR-1202 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Biological therapies, such as ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.